Crucible Therapeutics Limited
Research and experimental development on biotechnology · Sheffield
ActiveUnited KingdomIncorporated 2023Private Limited Company
Financial position
Accounts to 2026-02-28 · GBP · company scope
Net assets
£1,520,872
Cash
£1,804,883
Turnover
—
Profit / loss
—
Current assets
£1,912,187
Creditors < 1 year
£391,315
Equity
£1,520,872
Average employees
0.02
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2026-02-28GBP · company | 2025-02-28GBP · company |
|---|---|---|
| Balance sheet | ||
| Net assets | £1,520,872 | £1,051,518 |
| Equity | £1,520,872 | £1,051,518 |
| Assets | ||
| Current assets | £1,912,187 | £1,331,289 |
| Cash at bank | £1,804,883 | £1,258,030 |
| Debtors | £107,304 | £73,259 |
| Liabilities | ||
| Creditors within one year | £391,315 | £279,771 |
| Net current assets | £1,520,872 | £1,051,518 |
| People | ||
| Average employees | 0.02 | 0 |
| Source evidence | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesNo charges available in our records.